Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs COO✓SelectedUSD · COOMRNA vs COO performance historyLatest closeAs of+5.38%09/11
Stock and ETF performance explorer

MRNA vs COO

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+674.0%
COO return
-18.1%
Excess return
+692.1%
Maximum drawdown
-95.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCOOExcessAlpha
1D+5.4%-0.5%+5.9%+5.6%
7D-1.1%-22.5%+21.4%+8.4%
30D+126.1%-29.7%+155.9%+157.8%
3M+190.0%-20.1%+210.2%+215.1%
6M+157.2%-26.9%+184.1%+188.2%
YTD+388.2%-34.2%+422.4%+468.7%
1Y+467.0%-21.3%+488.3%+520.0%
3Y+36.1%-38.7%+74.7%+58.9%
5Y-68.0%-52.2%-15.8%-61.8%
All+674.0%-18.1%+692.1%+645.8%

Cumulative growth

Daily Returns

Daily percentage return beside COO.

Daily Out/Under-Performance

Portfolio return minus COO return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × COO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded COO wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling